カテゴリ： GlobalData, アメリカ, 企業調査

Transgenomic Inc (TBIO)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Transgenomic Inc (TBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011464
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月22日
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic systems, tissue microarray platforms and WAVE DHPLC systems. Transgenomic provides specimen collection kits including cardiology kits, neurology kits, oncology kits, pharmacogenomic kits, scoliscore AIS prognostic kits and whole exome sequencing kits. The company offers personalized medicine in oncology, cardiology, neurology, and inherited diseases. It provides patient testing services for cardiology, neurology, mitochondrial disorders and oncology. The company operates through its office located in Connecticut, the US. Transgenomic is headquartered in Omaha, Nebraska, the US.

Transgenomic Inc (TBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Transgenomic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Transgenomic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million 12
Partnerships 14
LifeLabs Enters into Licensing Agreement with Transgenomic 14
University of Melbourne Enters into Licensing Agreement with Transgenomic 15
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 16
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 17
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute 18
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 19
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 20
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 21
Transgenomic Enters Into Distribution Agreement With ScreenCell 22
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 23
Transgenomic Expands Licensing Agreement with Exiqon 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 25
Equity Offering 26
Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 26
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 28
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 29
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 30
Transgenomic Raises USD7 Million in Private Placement of Shares 32
Transgenomic Completes Private Placement Of Shares For USD8.3 Million 33
Transgenomic Completes Private Placement Of Shares For US$19 Million 34
Debt Offering 35
Transgenomic Raises USD1.2 Million in Private Placement 35
Asset Transactions 36
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 36
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 37
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 38
Acquisition 39
Transgenomic Acquires Precipio Diagnostics 39
Transgenomic Inc – Key Competitors 40
Transgenomic Inc – Key Employees 41
Transgenomic Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
Aug 12, 2016: Transgenomic Reports Second Quarter 2016 Financial Results 43
May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results 45
Apr 14, 2016: Transgenomic Reports Full Year 2015 Financial Results 47
Legal and Regulatory 49
Mar 09, 2016: Ground-breaking settlement changes landscape for genetic medicine in Canada 49
Product News 50
Jun 13, 2017: European Patent Office Confirms Grant of New ICE COLD-PCR Patent Exclusively Licensed to Transgenomic 50
Jun 14, 2016: Transgenomic Accelerates Commercialization of ICE COLD-PCR (ICP) amid Plans to Expand Cancer Product Line Ten-Fold 51
Jun 07, 2016: Transgenomic Releases New Data at ASCO 2016 Conference Confirming Concordance of ICE COLD-PCR Liquid and Tissue Biopsies 52
May 16, 2016: Transgenomic Study Data Shows 100% Concordance between ICE COLD-PCR (ICP) Liquid Biopsies and Conventional Tissue Biopsy Results; ICP Also Identifies More Tumor Mutations Than Conventional Methods 53
Mar 29, 2016: Transgenomic to Present Data Confirming Utility of ICE COLD-PCR Liquid Biopsy Technology at American Association for Cancer Research 2016 Annual Meeting 54
03/18/2016: Transgenomic Launches First Commercially Available Assay for Ultra Low Level Detection of EGFR C797S Mutations that Predict Resistance to Third Generation Kinase Therapies for Lung Cancer 55
03/10/2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Colorectal Tumor Mutations 56
03/10/2016: Transgenomic Launches New MX-ICP Liquid Biopsy Test for Comprehensive Detection of Melanoma Tumor Mutations 57
Jan 26, 2016: Transgenomic Highlights Unique Advantages of Multiplexed ICE COLD-PCR at Personalized Medicine World Conference 58
Jan 19, 2016: Transgenomic Launches New MX-ICP Panels for Liquid Biopsy Detection of RAS and PIK3CA Tumor Mutations 59
Other Significant Developments 60
Sep 29, 2016: Transgenomic Adds New Distributors in China and India for its ICEme Kits that Enable Liquid Biopsy Cancer Testing on Existing Platforms 60
Aug 08, 2016: VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Transgenomic Inc, Medical Equipment, Key Facts, 2016 2
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Transgenomic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Transgenomic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Transgenomic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Transgenomic Inc, Deals By Market, 2011 to YTD 2017 9
Transgenomic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million 12
LifeLabs Enters into Licensing Agreement with Transgenomic 14
University of Melbourne Enters into Licensing Agreement with Transgenomic 15
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 16
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 17
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute 18
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 19
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 20
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 21
Transgenomic Enters Into Distribution Agreement With ScreenCell 22
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 23
Transgenomic Expands Licensing Agreement with Exiqon 24
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 25
Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 26
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 28
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 29
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 30
Transgenomic Raises USD7 Million in Private Placement of Shares 32
Transgenomic Completes Private Placement Of Shares For USD8.3 Million 33
Transgenomic Completes Private Placement Of Shares For US$19 Million 34
Transgenomic Raises USD1.2 Million in Private Placement 35
ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 36
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 37
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 38
Transgenomic Acquires Precipio Diagnostics 39
Transgenomic Inc, Key Competitors 40
Transgenomic Inc, Key Employees 41
Transgenomic Inc, Other Locations 42
Transgenomic Inc, Subsidiaries 42

★海外企業調査レポート[Transgenomic Inc (TBIO)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Whole Foods Market Inc：戦略・SWOT・企業財務分析
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Furukawa Electric Co Ltd (FUWAY)：企業の財務・戦略的SWOT分析
    Furukawa Electric Co Ltd (FUWAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Moximed Inc：医療機器：M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Hurtigruten AS：企業の戦略・SWOT・財務情報
    Hurtigruten AS - Strategy, SWOT and Corporate Finance Report Summary Hurtigruten AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野：企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Sequana SA (SEQ)：企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ecopetrol S.A.：企業の戦略・SWOT・財務情報
    Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • East Japan Railway Co：企業の戦略・SWOT・財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Jouve SA：企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Bio-Rad Laboratories Inc (BIO)：企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Abbott Diagnostics：企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Khatam al-Anbia：企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Metalloinvest MC LLC：企業の戦略的SWOT分析
    Metalloinvest MC LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Sage Therapeutics Inc (SAGE)：製薬・医療：M&Aディール及び事業提携情報
    Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The company ha …
  • Wolters Kluwer nv：企業の戦略・SWOT・財務分析
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Quaker Chemical Corp (KWR)：企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Haverty Furniture Companies, Inc. (HVT)：企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Mehler Vario System GmbH：企業の戦略・SWOT・財務情報
    Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report Summary Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆